• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌气虚痰湿证的生物标志物鉴定。

Identification of Biomarkers for Lung Adenocarcinoma With Qi Deficiency and Phlegm Dampness.

机构信息

Department of Oncology, Tongde Hospital of Zhejiang, affiliated to Zhejiang Chinese Medicine University, Hangzhou, China.

Department of Respiratory, Jinhua Guangfu Hospital, Jinhua, China.

出版信息

Clin Respir J. 2024 Aug;18(8):e13812. doi: 10.1111/crj.13812.

DOI:10.1111/crj.13812
PMID:39107932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11303266/
Abstract

BACKGROUND

Qi deficiency and phlegm dampness (QPD) is one of the most common traditional Chinese medicine (TCM) syndromes in lung adenocarcinoma (LUAD). This study aimed to identify syndrome-specific biomarkers for LUAD with QPD syndrome.

METHODS

Peripheral blood mononuclear cells (PBMCs) from LUAD patients with QPD, LUAD patients with non-QPD (N-QPD), and healthy control (H) were collected and analyzed with RNA-seq to identify differentially expressed genes (DEGs). The area under the receiver operator characteristic curve (AUC) of each DEG was calculated, and the top 10 highest AUC DEGs were validated by qRT-PCR. Logistic regression analysis was used to develop a diagnostic model evaluated with AUC.

RESULTS

A total of 135 individuals were enrolled in this study (training set: 15 QPD, 15 N-QPD, 15 H; validation set: 30 QPD, 30 N-QPD, 30 H). A total of 1480 DEGs were identified between QPD and N-QPD. The qRT-PCR results showed that the expression of DDR2 was downregulated, and PPARG was upregulated, which was in line with the finding of the training set. We developed a diagnostic model with these two genes. The AUC of the diagnostic model in the training cohort and validation cohort was 0.891 and 0.777, respectively.

CONCLUSIONS

We identified the two genes (DDR2 and PPARG) as syndrome-specific biomarkers for LUAD with QPD syndrome and developed a novel diagnostic model, which may help to improve the accuracy and sensibility of clinical diagnosis and provide a new target for natural drug treatment of LUAD.

摘要

背景

气阴两虚夹痰证(QPD)是肺腺癌(LUAD)中最常见的中医(TCM)证候之一。本研究旨在鉴定 LUAD 伴 QPD 证候的证候特异性生物标志物。

方法

收集 LUAD 伴 QPD、LUAD 不伴 QPD(N-QPD)和健康对照(H)患者的外周血单核细胞(PBMCs),并进行 RNA-seq 分析以鉴定差异表达基因(DEGs)。计算每个 DEG 的受试者工作特征曲线下面积(AUC),并通过 qRT-PCR 验证 top10 个 AUC 最高的 DEGs。采用逻辑回归分析构建 AUC 评估的诊断模型。

结果

本研究共纳入 135 名患者(训练集:15 例 QPD、15 例 N-QPD、15 例 H;验证集:30 例 QPD、30 例 N-QPD、30 例 H)。QPD 与 N-QPD 之间共鉴定出 1480 个 DEGs。qRT-PCR 结果显示 DDR2 表达下调,PPARG 表达上调,与训练集结果一致。我们基于这两个基因构建了一个诊断模型。该诊断模型在训练集和验证集的 AUC 分别为 0.891 和 0.777。

结论

我们鉴定出 DDR2 和 PPARG 这两个基因作为 LUAD 伴 QPD 证候的证候特异性生物标志物,并构建了一个新的诊断模型,这可能有助于提高临床诊断的准确性和敏感性,并为 LUAD 的天然药物治疗提供新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/13aaaa15774c/CRJ-18-e13812-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/30cd2064e161/CRJ-18-e13812-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/6e5589eeac23/CRJ-18-e13812-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/932154d7500c/CRJ-18-e13812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/f346bb01fa98/CRJ-18-e13812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/e8198f02b17c/CRJ-18-e13812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/fbcb2649a277/CRJ-18-e13812-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/13aaaa15774c/CRJ-18-e13812-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/30cd2064e161/CRJ-18-e13812-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/6e5589eeac23/CRJ-18-e13812-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/932154d7500c/CRJ-18-e13812-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/f346bb01fa98/CRJ-18-e13812-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/e8198f02b17c/CRJ-18-e13812-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/fbcb2649a277/CRJ-18-e13812-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff4/11303266/13aaaa15774c/CRJ-18-e13812-g006.jpg

相似文献

1
Identification of Biomarkers for Lung Adenocarcinoma With Qi Deficiency and Phlegm Dampness.肺腺癌气虚痰湿证的生物标志物鉴定。
Clin Respir J. 2024 Aug;18(8):e13812. doi: 10.1111/crj.13812.
2
A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.双环状 RNA 特征作为肺腺癌的非侵入性诊断生物标志物。
J Transl Med. 2019 Feb 18;17(1):50. doi: 10.1186/s12967-019-1800-z.
3
Analysis of Gut Microbiota as a Diagnostic Biomarker for Lung Adenocarcinoma with Qi-Deficiency and Phlegm-Turbid Stagnation.基于气虚痰浊证型的肠道菌群作为肺腺癌诊断生物标志物的分析
Comb Chem High Throughput Screen. 2024 Jun 5. doi: 10.2174/0113862073303081240521083505.
4
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
5
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.分泌蛋白 MDK、WFDC2 和 CXCL14 作为肺腺癌早期诊断的候选生物标志物。
BMC Cancer. 2023 Jan 31;23(1):110. doi: 10.1186/s12885-023-10523-z.
6
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.一种新的与铁死亡相关的基因模型用于肺腺癌的预后预测。
BMC Pulm Med. 2021 Jul 13;21(1):229. doi: 10.1186/s12890-021-01588-2.
7
A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.基于 TCGA 数据挖掘的肺腺癌预后 14 基因表达特征研究。
Oxid Med Cell Longev. 2020 Dec 19;2020:8847226. doi: 10.1155/2020/8847226. eCollection 2020.
8
Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.鉴定一种新型治疗候选物 NRK 在肺腺癌微环境中原发性癌相关成纤维细胞中的作用。
J Cancer Res Clin Oncol. 2021 Apr;147(4):1049-1064. doi: 10.1007/s00432-020-03489-z. Epub 2021 Jan 2.
9
[Study on traditional Chinese medicine common syndrome characteristic of coronavirus disease 2019 based on latent structure combined with system clustering analysis].基于潜在结构结合系统聚类分析的2019冠状病毒病中医常见证候特征研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):537-543. doi: 10.3760/cma.j.cn121430-20200506-00620.
10
Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.鉴定九个 microRNAs 作为肺腺癌的潜在生物标志物。
FEBS Open Bio. 2019 Jan 9;9(2):315-327. doi: 10.1002/2211-5463.12572. eCollection 2019 Feb.

本文引用的文献

1
Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer.非小细胞肺癌患者靶向治疗的最新观点
J Pers Med. 2023 Jan 17;13(2):167. doi: 10.3390/jpm13020167.
2
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.益肺散结方联合安罗替尼二线及以上治疗晚期非小细胞肺癌的随机双盲安慰剂对照研究方案。
Integr Cancer Ther. 2023 Jan-Dec;22:15347354221151147. doi: 10.1177/15347354221151147.
3
Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities.
双相情感障碍复杂网络中的微生物群-肠-脑轴机制:潜在的临床意义及转化机遇
Mol Psychiatry. 2023 Jul;28(7):2645-2673. doi: 10.1038/s41380-023-01964-w. Epub 2023 Jan 27.
4
Exploring histopathological and serum biomarkers in lung adenocarcinoma: Clinical applications and translational opportunities (Review).探讨肺腺癌的组织病理学和血清生物标志物:临床应用和转化机会(综述)。
Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5444. Epub 2022 Oct 20.
5
PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma.过氧化物酶体增殖物激活受体γ(PPARG)可作为治疗肺鳞状细胞癌的有效治疗策略。
PPAR Res. 2020 Jun 1;2020:2510951. doi: 10.1155/2020/2510951. eCollection 2020.
6
PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma.PPARG作为肺腺癌病理发展和进展的抑制剂驱动分子网络。
PPAR Res. 2020 Apr 26;2020:6287468. doi: 10.1155/2020/6287468. eCollection 2020.
7
Global Epidemiology of Lung Cancer.全球肺癌流行病学。
Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419.
8
Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays.利用转录组芯片鉴定血浆RGS18和PPBP mRNA作为胃癌的潜在生物标志物。
Oncol Lett. 2019 Jan;17(1):247-255. doi: 10.3892/ol.2018.9608. Epub 2018 Oct 23.
9
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.